by admin | Nov 11, 2019 | Partnerships
Bioeq announced that it signed a license and development agreement with Coherus BioSciences, under which Coherus will exclusively market and distribute Bioeq’s biosimilar candidate to Lucentis (ranibizumab) in the United States. Coherus BioSciences is a leading...
by admin | Nov 4, 2019 | FDA
US-based medical device company Impulse Dynamics has secured the US FDA Supplemental-PMA approval for its next-generation, two-lead Optimizer Smart System intended for the treatment of heart failure. Impulse Dynamics has designed the Optimizer Smart System as an...
by admin | Nov 4, 2019 | Partnerships
PredictImmune, developers of pioneering prognostic tools for guiding treatment options in immune-mediated diseases, confirmed that it has entered into a commercial partnership with Theradiag, a pioneering European diagnostic company specialising in in vitro...
